Gucci sales slump continues as market awaits turnaround
  • February 10, 2025

Gucci sales slump continues as market awaits turnaround

Luxury group Kering said its return to growth will take time after its embattled star label Gucci posted another quarter of weak sales and has yet to name a new chief designer to galvanise the Italian brand. Shares in Kering jumped in early trade on Tuesday, before paring gains, as the market briefly seized on hopes the company had reached an inflection point. The French group said its sales fell 12% in October-December on a comparable basis from a year earlier, dragged down by a 24% drop at Gucci, which accounts for nearly half of group sales and two thirds of recurring operating profit but continues to struggle.

Medpace (NASDAQ:MEDP) Posts Q4 Sales In Line With Estimates But Stock Drops
  • February 10, 2025

Medpace (NASDAQ:MEDP) Posts Q4 Sales In Line With Estimates But Stock Drops

Clinical research company Medpace Holdings (NASDAQ:MEDP) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 7.7% year on year to $536.6 million. On the other hand, the company’s full-year revenue guidance of $2.16 billion at the midpoint came in 3.5% below analysts’ estimates. Its GAAP profit of $3.67 per share was 24.1% above analysts’ consensus estimates.

Amkor (NASDAQ:AMKR) Misses Q4 Analysts’ Revenue Estimates, Stock Drops
  • February 10, 2025

Amkor (NASDAQ:AMKR) Misses Q4 Analysts’ Revenue Estimates, Stock Drops

Semiconductor packaging and testing company Amkor Technology (NASDAQ:AMKR) fell short of the market’s revenue expectations in Q4 CY2024, with sales falling 7% year on year to $1.63 billion. Next quarter’s revenue guidance of $1.28 billion underwhelmed, coming in 14.1% below analysts’ estimates. Its GAAP profit of $0.43 per share was 16.2% above analysts’ consensus estimates.